TC-O9311 is primarily utilized in research settings as a potent and selective agonist for the GPR6 receptor, which is a G protein-coupled receptor expressed in the central nervous system. Its application is significant in neuroscience studies, particularly in understanding the role of GPR6 in neurological processes and disorders. Researchers use TC-O9311 to investigate its potential therapeutic effects in conditions such as Parkinson's disease, where modulation of GPR6 activity may influence motor control and dopamine-related pathways. Additionally, it serves as a valuable tool in pharmacological studies to explore receptor signaling mechanisms and develop novel treatments targeting GPR6. Its specificity makes it a crucial compound for advancing knowledge in neuropharmacology and drug discovery.